Effect of Diabetes Mellitus on Cardiac Autonomic Function in Surgical Patients Undergoing General Anesthesia
NCT ID: NCT06432270
Last Updated: 2024-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
388 participants
OBSERVATIONAL
2024-06-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Adverse Cardiovascular Event in Type-2 Diabetic Patients
NCT04579406
Changes of Cognitive Function and Orphanin FQ in Diabetic Patients Under General Anesthesia.
NCT04576767
The Risk Factors of Cardiovascular Disease in Elderly Diabetic Patients: A Prospective Cohort Study
NCT04544527
Long-term Mortality in Diabetics Undergoing Major Surgery
NCT00286572
The Body Constitution and Quality of Life of Diabetic
NCT01060332
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
diabetic group
Patients with a diagnosis of diabetes mellitus who are about to undergo general anesthesia who are expected to undergo laparoscopic surgery
No interventions assigned to this group
Non-diabetic group
Nondiabetic patients anticipating laparoscopic surgery who are about to undergo general anesthesia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI index of 18-35 kg/m2 (including 18 kg/m2 and 35 kg/m2 );
* Diagnosed with diabetes mellitus;
* ASA Ⅰ - Ⅱ;
* Elective laparoscopic abdominal surgery under general anesthesia;
* Operating time \>2 hours and \<6 hours;
* Voluntary participation and signing of an informed consent form;
* Ability to be followed up in a timely manner.
Exclusion Criteria
* Core body temperature ≥37.5 degrees Celsius;
* Patients with previous clear central nervous system disease, history of psychiatric disorders, or epilepsy;
* Patients with verbal communication or hearing or visual impairment, who were unable to communicate well and had poor compliance;
* Intraoperative use of vasodilator (uradil, sodium nitroprusside, nitroglycerin);
* Any high-risk subjects with complete atrioventricular block or complete atrioventricular conduction tissue without implanted pacemakers, multiple premature ventricular beats, single premature ventricular beats (heart rate \<45 beats/min), heart failure in NYHA (New York Heart Association) class III or higher;
* Subjects with any other clinically significant 12-lead electrocardiogram (ECG) or echocardiogram abnormality at the time of screening, ejection fraction (EF) \<40%, or any other significant abnormality in the opinion of the investigator;
* Subjects deemed by the investigator to be unfit for this clinical trial for any other reason (anesthesia assessment unfit for surgery or preanesthetic hypertension).
Withdrawal Criteria:
* Serious adverse events, abnormal laboratory tests, or other conditions that indicate no further benefit or increased risk to the subject's safety from continued participation in the study;
* Incomplete recording of critical data (temperature or heart rate variability);
* Unstable condition requiring further admission to the intensive care unit;
* Intraoperative use of dexmedetomidine; 5. Perioperative nerve block.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhujiang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhujiang Hospital of Southern Medical University
Role: STUDY_CHAIR
Southern Medical University, China
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-KY-209-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.